NCOR2 and prostate carcinoma: For prostate cancer, in GEE models rs906304 (rank 27, p = 0.000067), is in NCOR2 also known as SMRT. SMRT levels have been reported to be elevated in prostate cancer cells, and result in suppression of anti-proliferative target gene actions for the vitamin D receptor [11,12].